Remote monitoring and telemedicine improve systolic HF management, especially for patients in remote areas, by enhancing treatment adherence and outcomes. Wearable cardioverter-defibrillators and ...

In the first randomized clinical trial of remote pulmonary artery pressure–guided monitoring and management of chronic heart failure (HF) in Europe, the intervention "substantially" improved quality ...

Patients with moderately symptomatic heart failure (HF) and elevated levels of NT-proBNP, but no recent HF hospitalization, see significant clinical and quality-of-life benefits from pulmonary artery ...

PRAGUE, Czechia—Using a pulmonary artery pressure (PAP) monitor on top of best medical care results in significant improvements in quality of life and “substantial” reductions in heart failure (HF) ...

MONITOR-HF is the third randomized, controlled trial globally to show a significant health benefit for indicated heart failure patients CardioMEMS is a paperclip-sized sensor that can remotely flag to ...

The CardioMEMS HF System is proven to significantly reduce heart failure hospitalizations and improve quality of life in NYHA class III HF patients St. Jude Medical now intends to exercise its ...

Please provide your email address to receive an email when new articles are posted on . A novel stick-on monitor could reduce HF readmissions by 7% vs. controls. The number needed to treat to avoid ...

Please provide your email address to receive an email when new articles are posted on . In a meta-analysis of three trials, remote hemodynamic monitoring was associated with reduced risk for death and ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For a range of ...

GAITHERSBURG, MD (updated) — A Food and Drug Administration (FDA) advisory committee narrowly voted in favor of a novel device that measures pulmonary-artery (PA) pressures in patients with heart ...